Blue Horseshoe Stocks: Pharma News

Pharma News Drives Sector

Somewhat of a reversal of fortunes has befallen major healthcare middlemen this week, and for them it’s good news. The Trump administration is doing a 180° on proposed changes to drug rebates that would have cost the healthcare industry.

The development is causing healthcare stocks to rise here in the premarket, and a few that have caught our eye in particular, are UNH, CI, and CVS. Each of these plays is flying high in early trading, so what we’re going to look for is a classic dip-and-rip scenario. Profit-taking right out of the starting gate should drive these stocks down off of their lofty premarket highs, and that’s when where we come in with the following ideas.

CVS Health Corp. CVS Weekly $57-58.50 Calls
Cigna Corp. CI $167.50-175 Calls
United Health Corp. UNH $250-255 Calls 


Extended Watchlist:
PCG, NAVB, TRNX, OMER, ATOS, HTGM, DPLO, KBLB

Blue Horseshoe Stocks: Wednesday’s Runners, Fresh Ideas

Reviewing Yesterday’s Runners

To start off the week yesterday morning we formulated a trio of fresh options idea to track, and we can gladly announce that all three produced the opportunity to net multibag gains. Our options ideas have been as good in 2019 as any time in our eight year history, and we ain to keep that trend going!

Take a look at yesterday’s fresh ideas, and the bullish activity they recorded:

KNDI Weekly $6-7 Calls

$6 Calls – Range: 1.35-2.90 – Max Gain: 115%
$7 Calls – Range: .72-2.10 – Max Gain: 192%
_____

GDXJ Weekly $34-34.50 Calls

$34 Calls – Range: .52-1.02 – Max Gain: 96%
$34.50 Calls – Range: .26-.58 – Max Gain: 123%
_____

GRMN Weekly $74.50-76.50 Calls

$74.50 Calls – Range:
2.90-8.06 – Max Gain: 178%
$75 Calls – Range: 1.52-8.35 – Max Gain: 449%
(There are no $75.50 Calls)
$76 Calls – Range: .71-6.80 – Max Gain: 858%
$76.50 Calls – Range: .72-6.12 – Max Gain: 750%
_____

Fresh Options Ideas – In addition to continuing to keep an eye on the previously mentioned plays, we will also add to the pool with another couple of ideas today. In these cases we are going to go bearish.

Domino’s whiffed on earnings and revenue in its premarket release today, while same-store sales increased only slightly. Meanwhile, the high profile injury to Duke basketball player Zion Williamson last night caused by a Nike shoe malfunction, has the potential to have a deleterious effect on Nike’s stock in the near term.

Domino’s Pizza Inc. DPZ Weekly $270-260 Puts
Nike, Inc. NKE 03/15 $84-83.50 Puts


Extended Watchlist:
ESNC, CVRS, ATNM, HTGM, BOXL, GEVO, KL, GOGO

Blue Horseshoe Stocks: CAPR Recap & More

Capricor Therapeutics, Inc. CAPR

We included CAPR in yesterday’s premarket watchlist after noticing some abnormal volume and price action in the stock during the previous session. Prior to that it had been trading sideways for more than a month.

It turns out our alert came just in the nick of time, because yesterday CAPR exploded for its largest single-session spike in years. The stock opened at 1.50 and managed to run as high as 2.65, filling a good portion of the large gap on its chart, left in May. It came out to an intraday push of 77% which came on monstrous volume of just under 80 times the monthly average.


SPDR S&P500 ETF (SPY)

We discussed tracking the SPY Weekly $249.50 & $250 Calls as conditions appeared favorable to another bullish day for the market in general. The fund made a pretty solid move during the session, and that produced some decent opportunities in our designated contracts.

The $249.50’s traded from .55 to a high of .83 (+51%), while the $250’s did slightly better with a run from .29 to .49 (+69%) just before lunch hour.


Helios and Matheson Analytics, Inc. HMNY

We last tagged HMNY on August 15th, and after a solid run, the stock went under consolidation for a few weeks. However, the downturn ended at the end of last week and the move it’s made since has been pretty impressive.

HMNY saw a low of 2.42 on Thursday, and yesterday the stock achieved a new high of 6.40. That represents a four -session upswing of 164% while volume over the same period has been significantly increased.


HTG Molecular Diagnostics, Inc. HTGM

We’re interested to track HTGM today after the company announced the issuance of two method patents on its technology. We’re seeing a moderate gap-up in the premarket, but there still appears to be the good chance for a solid upside here. The stock does have a recent history containing a huge spike to more than $12.

We’ll place it on watch, and look for it to establish a string of sessions recording higher highs and higher lows moving forward.


Extended Watchlist:
WAC, DMPI, KPTI, SPI, ARWR, ALRT, PZRX, CEI